Discontinuation report TEVA-LAMOTRIGINE

Last updated on 2019-04-11 History
Report ID 81388
Drug Identification Number 02248232
Brand name TEVA-LAMOTRIGINE
Common or Proper name LAMOTRIGINE
Company Name TEVA CANADA LIMITED
Active Ingredient(s) LAMOTRIGINE
Strength(s) 25MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 100
ATC code N03AX
ATC description ANTIEPILEPTICS
Reason for discontinuation Business reasons
Anticipated discontinuation date
Actual discontinuation date 2019-01-09
Remaining supply date 2019-02-28
Discontinuation status Discontinued
Discontinuation decision reversal No
Information on remaining supply
Company comments
Health Canada comments
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v2 2019-04-11 French Compare
v1 2019-04-11 English Compare